Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics | Zendy

Kerstin AlbertssonWikland | Zendy; Anton Mårtensson | Zendy; Lars Sävendahl | Zendy; Aimon Niklasson | Zendy; Peter Bang | Zendy; Jovanna Dahlgren | Zendy; Jan Gustafsson | Zendy; Berit Kriström | Zendy; Svante Norgren | Zendy; Nils-Gunnar Pehrsson | Zendy; Anders Odén | Zendy

Open Access

Mortality Is Not Increased in Recombinant Human Growth Hormone-treated Patients When Adjusting for Birth Characteristics

Author(s) -

Kerstin AlbertssonWikland,

Anton Mårtensson,

Lars Sävendahl,

Aimon Niklasson,

Peter Bang,

Jovanna Dahlgren,

Jan Gustafsson,

Berit Kriström,

Svante Norgren,

Nils-Gunnar Pehrsson,

Anders Odén

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2015-3951

Subject(s) - medicine , pediatrics , population , hazard ratio , confidence interval , ighd , small for gestational age , standardized mortality ratio , birth weight , growth hormone deficiency , pregnancy , growth hormone , hormone , environmental health , biology , genetics

This study aimed to investigate whether reported high mortality in childhood recombinant human GH (rhGH)-treated patients was related to birth-characteristics and/or rhGH treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog